Keywords: crt, set, initiate, ph, trial, gsk, aurora

CRT set to initiate Ph I trial of GSK's aurora kinase blocker

Article | 20 May 2009

Print This

UK charity Cancer Research UK and its Cancer Research Technology unit will begin a Phase I trial of a cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in